Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by HighSkies2019on Nov 10, 2020 7:36pm
413 Views
Post# 31875095

Sedar Filings !

Sedar Filings !Well this is a start .... and it was on the sedar files ... under the CTO and reasons for why we Kly were halted and the issues against us...this is where I saw the change.. not to get too excited but what they just cleared off from yesterday to today ...was payment to securities....they posted paperwork Oct 28 and 29th ...applied for reinstatement nov 4....the sec reviewed and cleared ...and the securities now have their payment that's why it was brought current ... I think this is the start and anticipate tomorrow or next day another NR and possibly unhalted .... because Kly has 3 mos to get annual meeting complete and more info provided back to the sec or can be put back on halt .... this is imo .... not pumping ... not an insider with info .... just want this to get unhalted and hopefully make some cash glta
<< Previous
Bullboard Posts
Next >>